TEAM AESARA Increased Opportunities to Accelerate Patient Access To Life-Saving Treatments Where are you in your Journey? Chad Patel and Ashik Jayakumar Legislation provisions known
Sameera Tak Facing Biosimilar Competition: Value & Access Readiness Strategies Sameera Tak Biosimilars Loss of exclusivity is notorious for giving pharma and biotech executives sleepless
GAVIN OUTTERIDGE How biopharma innovators can benefit from the ACCESS Consortium and CAN/UK/AUS collaboration in HTA GAVIN OUTTERIDGE & BOB CLAY What’s happening now, across
GAVIN OUTTERIDGE The European Union’s new Health Technology Assessment (HTA) Regulation demands that innovative biotech and pharma companies submit a new type of value dossier
GAVIN OUTTERIDGE Building a common value & access strategy for a continent GAVIN OUTTERIDGE, CATHERINE CHAMOUX and RUSLAN HORBLYUK “Who do I call when I
JAYMIN PATEL, RICHARD H. STANFORD & TYLER REINSCH VISIONTherapeutic Numbers It’s the middle of August 2020 and everyone is on the edge of their seat